Authors:
MASELLIS M
BASILE V
MELTZER HY
LIEBERMAN JA
SEVY S
MACCIARDI FM
COLA P
HOWARD A
BADRI F
NOTHEN MM
KALOW W
KENNEDY JL
Citation: M. Masellis et al., SEROTONIN SUBTYPE-2 RECEPTOR GENES AND CLINICAL-RESPONSE TO CLOZAPINEIN SCHIZOPHRENIA-PATIENTS, Neuropsychopharmacology, 19(2), 1998, pp. 123-132
Authors:
POTKIN SG
KENNEDY J
BADRI F
JIN Y
MASELLIS M
KEATOR DB
FROST J
WU JC
NAJAFI A
Citation: Sg. Potkin et al., A GENETIC PET SCAN STUDY - D1 ALLELES PREDICT CLINICAL-RESPONSE TO CLOZAPINE AND CORRESPONDING BRAIN METABOLISM, American journal of medical genetics, 81(6), 1998, pp. 496-497
Authors:
POTKIN SG
KENNEDY J
BADRI F
JIN Y
MASELLIS M
GULASEKARAM B
COSTA J
KEATOR DB
TELFORD J
WU JC
NAJAFI A
Citation: Sg. Potkin et al., D1 ALLELES PREDICT CLINICAL-RESPONSE TO CLOZAPINE AND CORRESPONDING BRAIN METABOLISM - A GENETIC PET SCAN STUDY, Schizophrenia research, 24(1-2), 1997, pp. 92-92
Authors:
MASELLIS M
BADRI F
MACCIARDI FM
MELTZER HY
LIEBERMAN JA
NOTHEN MM
HAMBLIN M
KALOW W
KENNEDY JL
Citation: M. Masellis et al., PHARMACOGENETIC ANALYSIS OF THE SEROTONIN SYSTEM AND RESPONSE TO CLOZAPINE, American journal of medical genetics, 74(6), 1997, pp. 612-613
Authors:
SASAKI T
MACCIARDI FM
BADRI F
VERGA M
MELTZER HY
LIEBERMAN J
HOWARD A
BEAN G
JOFFE RT
HUDSON CJ
KENNEDY JL
Citation: T. Sasaki et al., NO EVIDENCE FOR ASSOCIATION OF DOPAMINE D2 RECEPTOR VARIANT (SER311 CYS311) WITH MAJOR PSYCHOSIS/, American journal of medical genetics, 67(4), 1996, pp. 415-417
Authors:
BADRI F
MASELLIS M
PETRONIS A
MARINO C
MACCIARDI FM
VANTOL HHM
COLA P
MELTZER HY
LIEBERMAN J
KENNEDY JL
Citation: F. Badri et al., GENETIC-STUDIES OF DOPAMINE AND SEROTONIN SYSTEM GENES IN CLINICAL-RESPONSE TO CLOZAPINE, American journal of human genetics, 57(4), 1995, pp. 1358-1358